ALAB Valuation

Astera Labs Inc

Add to Watchlist

Advanced Chart

59.480

+0.620(+1.050%)

Overview
Forecast
Valuation

ALAB Relative Valuation

ALAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALAB is overvalued; if below, it's undervalued.

Historical Valuation

Astera Labs Inc (ALAB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 46.20 is considered Undervalued compared with the five-year average of 95.77. The fair price of Astera Labs Inc (ALAB) is between 69.08 to 144.12 according to relative valuation methord. Compared to the current price of 59.38 USD , Astera Labs Inc is Undervalued By 14.04%.

Relative Value

Fair Zone

69.08-144.12

Current Price：59.38

14.04%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

9.78

P/B

Median3y

12.35

Median5y

12.35

0.98

FCF Yield

Median3y

0.44

Median5y

0.44

Competitors Valuation Multiple

The average P/S ratio for ALAB's competitors is 6.84, providing a benchmark for relative valuation. Astera Labs Inc Corp (ALAB) exhibits a P/S ratio of 15.45, which is 125.95% above the industry average. Given its robust revenue growth of 179.32%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap